Kouri Ioanna Pediatric Neurologist

Board Member

• Board certified, American Board of Neurology with special qualification in Child Neurology, certificate No 12794

• Board certified, American Board of Medical Specialties, Sleep Medicine Certification examination, certificate No 1612

• State of Minnesota Medical License (Unrestricted License type, MN, License No: 63286)

• Accreditation from ECFMG (Educational Commission for Foreign Medical Graduates, USA)

• Board certified in Pediatrics, Greece

Editorial Boards

• American Academy of Neurology

• American Academy of Sleep Medicine

• American Academy of Pediatrics

• World Sleep society

• Child Neurology Society

• Mayo Clinic Alumni Association

• Medical Association of Athens, Greece

• Hellenic Pediatric Neurology Society

Professional Experience

• Consultant in Pediatric Neurology and Sleep medicine at Mitera, Leto and Metropolitan Hospital in Athens, Greece.

• Consultant in Pediatric Neurology at ELEPAP (Association for children with neurodevelopmental disabilities), Athens, Greece.

• Academic Associate in First Department of Pediatrics in University of Athens, Greece

Education Experience

• Fellow physician in Sleep medicine, Mayo Clinic, Rochester, MN

• Resident physician in Child Neurology, University of Iowa Hospitals and Clinics, IA

• Resident physician in Pediatrics, “Aghia Sophia Children’s Hospital”, Athens, Greece

• Resident physician in Pediatrics, Community Hospital Arta, Greece

Clinical and Research Interest

Clinical Interest:

• Epilepsy

• Neuromuscular disorders

• Headache

• Pediatric stroke

• Parasomnias

• Sleep disordered breathing

Research Interest: 

• Pediatric stroke

• Central Sleep Apnea

• Circadian Rhythm Abnormalities

Awards

• Medical school University of Ioannina, Valedictorian

Recent Publications

• “Sleep and breathing following nusinersen therapy in a child with spinal muscular atrophy” Kouri I, Demirel N, Haile DT, Selcen, D, Kotagal S. J Clin Neuromuscul Dis. 2020 Dec;22(2):105-108

• “Postoperative outcomes in patients with treatment-emergent central sleep apnea: a case series”. Barman RA, Fields AR, Eells AJ, Kouri I, Mansukhani MP, Gali B, Sprung J, Weingarten TN. J Anesth. 2020 Jul 21.

• “Frequency and outcomes of primary central sleep apnea in a population-based study”. Kouri I, Kolla BP, Morgenthaler TI, Mansukhani MP. Sleep Med. 2019 Dec 24; 68:177-183

• “Facial Weakness and Ophthalmoplegia in a 4-Day-Old Infant”. Kouri I, Mathews K, Joshi C. Semin. Pediatr. Neurol. 2018 Jul; 26:63-66

• “HLA associations with multiple sclerosis in Greece.” Kouri I, Papakonstantinou S, Bempes V, Vasiliadis HS, Kyritsis AP, Pelidou SH. J Neurol Sci. 2011 Sep 15; 308(1-2):28-31

• “Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review.” Contopoulos-Ioannidis DG, Karvouni A, Kouri I, Ioannidis JP. BMJ. 2009 Jan 12; 338

• “International ranking systems for universities and institutions: a critical appraisal.” Ioannidis JP, Patsopoulos NA, Kavvoura FK, Tatsioni A, Evangelou E, Kouri I, Contopoulos – Ioannidis DG, Liberopoulos G. BMC Med. 2007 Oct 25; 5:30

• “Genetic predisposition to Asthma and Atopy”. Contopoulos-Ioannidis DG, Kouri IN, Ioannidis JP. Respiration 2007; 74:8-12

• “Pharmacogenetics of the response to b2- agonist drugs: a systemic overview of the field”. Contopoulos-Ioannidis DG, Kouri I, Ioannidis JP Pharmacogenomics 2007; 8(8),933-958